Predicting Time-to-conversion for Dementia of Alzheimer's Type using Multi-modal Deep Survival Analysis

summary

The gist

Dementia of Alzheimer’s Type (DAT) is a complex disorder influenced by numerous factors, but it is unclear how each factor contributes to disease progression Our findings showed that genetic…

In short

Researchers used a deep learning model to predict when patients would convert to Dementia of Alzheimer's Type (DAT) using MRI, genetic, and clinical data from 401 subjects. The study found that clinical features were most important for prediction, suggesting current cognitive tests are better than costly genetic or CSF data alone.

Key concepts

Deep Learning-based Survival Analysis Model
This is a sophisticated statistical method that uses a neural network to predict the time until an event occurs, like converting to DAT. It goes beyond traditional methods by learning complex patterns from multiple data types (MRI, genetics) simultaneously to estimate survival rates over time.
Feature Importance
This analysis determined which input variables—like MRI scans or genetic markers—had the biggest impact on the model's predictions. The study found that features from clinical cognitive tests were the most influential in accurately predicting DAT conversion.
Time-to-Conversion (TTC)
This is a crucial prediction: estimating exactly how long it will take for a patient to develop Dementia of Alzheimer's Type. The model helped identify risks early, with some subjects showing predicted risk earlier than the actual event occurred.

Terminology used across episodes

This episode discusses

The paper

Predicting Time-to-conversion for Dementia of Alzheimer's Type using Multi-modal Deep Survival Analysis · Read on arXiv

Ghazal Mirabnahrazam, Da Ma, Cédric Beaulac, Sieun Lee, Karteek Popuri, Hyunwoo Lee, иgiguo Cao, Нames E Galvin, 㹮 Lei Wang, Mirza Faisal Beg

School of Engineering, Simon Fraser University · School of Medicine, Wake Forest University · Department of Mathematics and Statistics, University of Victoria · Mental Health & Clinical Neurosciences, School of Medicine, University of Nottingham · Department of Computer Science, Memorial University of Newfoundland · Division of Neurology, Department of Medicine, University of British Columbia · Department of Statistics and Actuarial Science, Simon Fraser University · Comprehensive Center for Brain Health, Department of Neurology, University of Miami Miller School of Medicine · НPsychiatry and Behavioral Health, Ohio State University Wexner Medical Center

Dementia of Alzheimer's Type (DAT) is a complex disorder influenced by numerous factors, but it is unclear how each factor contributes to disease progression. An in-depth examination of these factors may yield an accurate estimate of time-to-conversion to DAT for patients at various disease stages. We used 401 subjects with 63 features from MRI, genetic, and CDC (Cognitive tests, Demographic, and CSF) data modalities in the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. We used a deep learning-based survival analysis model that extends the classic Cox regression model to predict time-to-conversion to DAT. Our findings showed that genetic features contributed the least to survival analysis, while CDC features contributed the most. Combining MRI and genetic features improved survival prediction over using either modality alone, but adding CDC to any combination of features only worked as well as using only CDC features. Consequently, our study demonstrated that using the current clinical procedure, which includes gathering cognitive test results, can outperform survival analysis results produced using costly genetic or CSF data.

DOI: 10.1016/j.neurobiolaging.2022.10.005

Transcript

Introduction to the show: ident: AI Radio. Generated commentary on the latest Artificial Intelligence papers.

Tom: We're looking at the paper: "Predicting Time-to-conversion for Dementia of Alzheimer's Type using Multi-modal Deep Survival Analysis".

Jane: Here's the gist of the paper. Dementia of Alzheimer’s Type (DAT) is a complex disorder influenced by numerous factors, but it is unclear how each factor contributes to disease progression Our findings showed that genetic features contributed the least to survival analysis, while CDC features contributed the most The study used 401 subjects with 63 features from MRI, genetic, and CDC data modalities in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database.

Tom: Study Design and Data Modalities The researchers utilized a multi-modal deep learning-based survival analysis model that extends the classic Cox regression model to predict time-to-conversion to DAT.

Jane: The dataset comprised 401 subjects with 63 features drawn from MRI, genetic, and CDC data modalities in the ADNI database.

Tom: Data stratification involved dividing subjects into five subgroups based on clinical diagnosis at baseline, which were then divided into two categories based on whether they received a clinical diagnosis of DAT in a future time point.

Paper summary: Tom: So we’ve covered the overview, but let’s really nail down what this paper is proposing. Essentially, it’s about predicting when someone will convert to Dementia of Alzheimer's Type by using a multi-modal deep survival analysis model.

Jane: Right. The core thesis is that combining different data modalities—MRI scans, genetic information, and clinical data like CDC features—can give us a better prediction for the time it takes for someone to develop DAT.

Lu: The paper claims that while many factors influence Alzheimer's Type progression, the exact contribution of each factor to this progression is still unknown. They are using this model to investigate that contribution by looking at how different data types work together in predicting DAT risk.

Meng: So they aren't just saying "MRI is good" or "Genetics is good"; they’re trying to map out the actual influence of each piece of information within the prediction framework.

Lalam: They used a dataset from the Alzheimer's Disease Neuroimaging Initiative, ADNI, with four hundred one subjects and sixty three features pulled from MRI, genetic data, and CDC data modalities. This is their input pool for testing this multi-modal approach.

Tom: And the key result they highlight is that CDC features contributed the most to the model performance in their survival analysis. That’s a major finding when you’re trying to prioritize which inputs are most influential.

Jane: It matters because it suggests that clinical data, specifically those cognitive test features from CDC, have a stronger signal for predicting DAT progression than genetic or structural imaging features alone in this setup.

Lu: They also found that cognitive performance tests were very important, with all ten COG features declared to have a positive effect on the outcome when using the CDC feature set. This points to the value of those specific cognitive measures.

Meng: So it’s not just about having lots of data; it's about knowing which subset is actually driving the prediction, and this paper gives us that breakdown by modality.

Lalam: They also found that genetic factors and CSF factors were less useful when they were looked at in single data types, emphasizing the need for integration to see their true impact.

Tom: And they showed that using current clinical procedures with cognitive test results can actually outperform survival analysis results generated when only using costly genetic or CSF data. That’s a big practical implication for how clinicians might approach initial risk assessment.

Jane: It means sticking to what's already being done clinically—getting those cognitive tests first—might give you a better initial prediction than relying solely on expensive biological information right off the bat.

Lu: They also showed that combining MRI and CDC features yielded the best overall performance, with just the CDC features being very close behind. That tells us about the optimal feature set for this model structure.

Meng: So for a production system, it seems like MRI and CDC is a solid starting point based on these results because of how well they performed against other combinations.

Lalam: The paper also showed that genetic data has the potential to detect risk in currently normal subjects, which opens up possibilities beyond just predicting progression in already sick patients.

Tom: So, to wrap this part up, the main claim is that multi-modal deep survival analysis can predict time-to-conversion for DAT, and it helps us understand which specific data features are most predictive.

Jane: And it matters because it shows that we can move toward models that use clinical data effectively to predict progression earlier than before.

Conclusion: Tom: Thinking about this whole thing, "Predicting Time-to-conversion for Dementia of Alzheimer's Type using Multi-modal Deep Survival Analysis" and the authors, Mirabnahrazam a et al., Da Ma a et al., Beaulac a et al., and the others.

Jane: They’ve done this complex work by building this deep learning survival model to see how different data types interact. The implications are that we can start using these tools to get earlier risk assessments for DAT, even if we don't have a cure yet.

Lu: The key implication is moving away from single-data-type reliance toward integrated systems where the prediction relies on combining clinical, genetic, and imaging data for better accuracy.

Meng: From an engineering standpoint, it means that when we build these tools, we need to ensure the model is robust enough to handle that mix of inputs without breaking at scale.

Lalam: It suggests that cognitive tests are a good starting point because they're fast and cheap, which makes them a pragmatic input for early risk prediction workflows.

Tom: So in simple terms, this paper shows us that we can use sophisticated AI to get an earlier warning signal for DAT by looking at how different data streams feed into the prediction.

Jane: And it matters because it gives us a concrete direction on which data sources are most likely to provide that

More episodes

← Home